Wave Life Sciences to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceGlobeNewsWire • 09/06/23
Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-006, the First-ever RNA Editing Clinical Candidate, and Plans for Upcoming Virtual “R&D Day”GlobeNewsWire • 09/05/23
Wave Life Sciences Reports Second Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 08/03/23
Wave Life Sciences Second Quarter 2023 Financial Results Scheduled for August 3, 2023GlobeNewsWire • 07/27/23
Wave Life Sciences Announces Topline Results from Phase 1b/2a FOCUS-C9 Study of WVE-004 for C9orf72-associated Amyotrophic Lateral Sclerosis and Frontotemporal DementiaGlobeNewsWire • 05/23/23
Wave Life Sciences to Highlight Leading RNA Editing Capability and Multimodal Discovery and Development Platform at ASGCT 26th Annual MeetingGlobeNewsWire • 05/16/23
Wave Life Sciences Reports First Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 05/03/23
Wave Life Sciences First Quarter 2023 Financial Results Scheduled for May 3, 2023GlobeNewsWire • 04/26/23
Wave Life Sciences Announces Nucleic Acids Research Publication Highlighting Potential Best-in-Class siRNAs Designed with Wave Platform ChemistryGlobeNewsWire • 04/20/23
Wave Life Sciences to Present at the Guggenheim Genomic Medicines and Rare Disease DaysGlobeNewsWire • 03/29/23
Wave Life Sciences (WVE) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 03/22/23
Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 03/22/23
Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023GlobeNewsWire • 03/02/23
Wave Life Sciences (WVE) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 02/14/23
After Plunging -23.26% in 4 Weeks, Here's Why the Trend Might Reverse for Wave Life Sciences (WVE)Zacks Investment Research • 02/14/23
Wave Life Sciences to Present at the 2023 Virtual SVB Securities Global Biopharma ConferenceGlobeNewsWire • 02/09/23